AMN1126
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AMN1126, covering 2026-02-19 to 2026-02-19. Get the full timeline:
Most recent: Clinical Trial Update: SAD Study to Evaluate Safety, Tolerability, and Pharmacokinetic Profile of AMN1126 in Healthy Post-Menopausal Females [Phase 1]